Search Results - "FINLEY, REBECCA S"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Overview of targeted therapies for cancer by Finley, RS

    Published in American journal of health-system pharmacy (15-12-2003)
    “…Targeted therapies for cancer are discussed. Research into the molecular biology of cancer has revealed critical differences between normal and tumor cells and…”
    Get full text
    Journal Article Conference Proceeding
  5. 5

    Meta-Analysis of Interventions for Medication Adherence to Antihypertensives by Takiya, Liza N, Peterson, Andrew M, Finley, Rebecca S

    Published in The Annals of pharmacotherapy (01-10-2004)
    “…OBJECTIVE To identify methods targeted at improving adherence to antihypertensives and determine their effect on adherence using meta-analytic techniques…”
    Get full text
    Journal Article
  6. 6

    Bisphosphonates in the treatment of bone metastases by Finley, Rebecca S

    Published in Seminars in oncology (01-02-2002)
    “…Bone metastases are one of the most common problematic complications of advanced cancers. In addition to causing significant pain, bone metastases often result…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10

    Cisplatin nephrotoxicity: a summary of preventative interventions by Finley, R S, Fortner, C L, Grove, W R

    Published in Drug intelligence & clinical pharmacy (01-05-1985)
    “…Nephrotoxicity is usually the dose-limiting toxicity associated with cisplatin therapy. Frequently the nephrotoxicity is mild and reversible. However, it is…”
    Get more information
    Journal Article
  11. 11

    New Directions in the Treatment of Cancer: Inhibition of Signal Transduction by Finley, Rebecca S.

    Published in Journal of pharmacy practice (01-02-2002)
    “…In recent years, it has become increasingly apparent that proteins regulated by activated oncogenes or mutated tumor suppressor genes are responsible for the…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Measuring the cost-effectiveness of hematopoietic growth factor therapy by Finley, R S

    Published in Cancer (15-05-1991)
    “…The increasing cost of and demand for health care have intensified the concern that some form of health care rationing is inevitable. Cost studies require the…”
    Get more information
    Journal Article
  17. 17

    Patient care issues: the management of paclitaxel-related toxicities by Finley, R S, Rowinsky, E K

    Published in The Annals of pharmacotherapy (01-05-1994)
    “…At the low-to-moderate doses that are recommended, paclitaxel is a well-tolerated drug. Although adverse reactions do occur, most of these are manageable and…”
    Get more information
    Journal Article
  18. 18
  19. 19
  20. 20

    Drug interactions in the oncology patient by Finley, R S

    Published in Seminars in oncology nursing (01-05-1992)
    “…Cancer patients receiving chemotherapy often require a wide range of drugs to manage symptoms of their cancer, the side effects of the chemotherapy or…”
    Get more information
    Journal Article